Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513194) titled 'GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)' on April 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Baylor College of Medicine

Condition: Atypical Teratoid Rhabdoid Tumor Central Nervous System Rhabdoid Tumor

Intervention: Biological: 21.15.GPC3-CAR T Cells...

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 1, 2026

Target Sample Size: 21

Countries of Recruitment: United States

To know m...